Dholaria, Bhagirathbhai R.
Bachmeier, Christina A.
Locke, Frederick http://orcid.org/0000-0001-9063-6691
Funding for this research was provided by:
National Cancer Institute (CA201594, CA076292-18S4)
Article History
First Online: 17 December 2018
Compliance with Ethical Standards
:
: This work was supported by an NCI K23 award (PI- Locke, F; CA201594, NIH/NCI) and an NCI Cancer Center support grant P30 (CA076292-18S4, NIH/NCI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
: Frederick Locke declares being a scientific advisor to Kite (a Gilead subsidiary) and Novartis; and a consultant for Cellular BioMedicine Group. Bhagirathbhai R. Dholaria and Christina Bachmeier declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.